Next Generation Sequencing Market, by Technology, 2012 – 2022 (USD Billion)Ħ.1.1.3. Next Generation Sequencing Market, by Application, 2012 – 2022 (USD Billion)Ħ.1.1.2. Next Generation Sequencing Regional OutlookĦ.1.1.1. NGS Data Analysis Market Estimates and Forecasts, 2012 – 2022 (USD Billion)Ĭhapter 6. NGS Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)ĥ.3.1. NGS Pre-sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)ĥ.2.1. Next Generation Sequencing Workflow Outlookĥ.1.1. Targeted Sequencing & Resequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)Ĭhapter 5. Whole Exon Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)Ĥ.3.1. Whole Genome Sequencing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)Ĥ.2.1. Next Generation Sequencing Technology OutlookĤ.1.1. Infectious Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)Ĭhapter 4. Idiopathic Diseases Market Estimates and Forecasts, 2012 – 2022 (USD Billion)ģ.5.1. Oncology Market Estimates and Forecasts, 2012 – 2022 (USD Billion)ģ.4.1. Prenatal Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)ģ.3.1. HLA Testing Market Estimates and Forecasts, 2012 – 2022 (USD Billion)ģ.2.1. Next Generation Sequencing Application Outlookģ.1.1. Product and competitive landscape analysisĬhapter 3. Next Generation Sequencing Market PESTEL Analysis, 2014Ģ.8. Key Opportunities Prioritized & Platform PositioningĢ.6. Next Generation Sequencing Market DynamicsĢ.5. Next Generation Sequencing Industry OutlookĢ.3. Next Generation Sequencing – Industry Snapshot and Key Buying Criteria, 2012 - 2022Ĭhapter 2. Heavy R&D investment for the development of genome sequencing,, rising adoption rates of whole genome sequencing, existence of the framework for the sophisticated technology and the reduction in sequencing cost per base pair are few of the factors responsible for the largest market share of North American geography.ġ.1. In 2014, North America emerged as the major regional market. Rise in the extensive R&D initiatives and the demand for storage and analysis are the key factors contributing to its fast growth. The segment growth would experience a trigger with the rising demand for personalized medicine and introduction of technologically advanced genome sequencing platforms during the forecast period.įurther, the Next generation sequencing based data analysis is anticipated to grow at a noticeably growth rate during the forecast period. In 2014, the Next generation sequencing emerged as the largest workflow segment of the market. However, as a result of the introduction of the techniques useful for phase-resolved HLA and prenatal sequences in single cycle reads, the growth rate of the use of NGS in fields of HLA and prenatal testing are estimated to be relatively higher till 2022. The next generation sequencing based oncology market is anticipated to top the market value during the forecast period. Rising incidences of life frightening forms of cancer and infectious diseases would fuel the growth of this segment during the forecast period. In 2014, the Targeted sequencing & resequencing emerged as the leading technology segment of the market as a result of the swiftly rising demand in oncology and infectious diseases related research. (Roche Holding AG), Life Technologies (Thermo Fisher Scientific), Agilent Technologies Inc., Macrogen Inc., Pacific Biosciences, Beijing Genomics Institute, CLC bio (Qiagen), Illumina Inc., Biomatters Ltd., DNASTAR Inc., Qiagen NV., Knome Inc., Oxford Nanopore Technologies and Helicos BioSciences. The major market participants of the next generation sequencing market include GATC Biotech AG., 454 Life Sciences Corp. Further, the rise in the rate of incidences of cancer and infectious diseases would fuel the growth of the next generation sequencing market during the forecast period. As a result of the introduction of novel phase resolved single cycle reads, the HLA and prenatal testing segments are expected to witness increase in the respective revenues. The technological developments in genomic sequencing would lead to reduction in the sequencing cost per base pair and hence, resulting in enhancement of the usage and adoption usage rates of next generation sequencing during the forecast period. The next generation sequencing market worldwide is anticipated to attain a market size of more than USD 25 billion by year 2022.